Withania somnifera chemotypes NMITLI 101R, NMITLI 118R, NMITLI 128R and withaferin A protect Mastomys coucha from Brugia malayi infection

Parasite Immunology

Volumn 34, Issue 4, 2012, Pages 199-209

  Kushwaha, S ^a   Soni, V K ^a   Singh, P K ^a   Bano, N ^a   Kumar, A ^b   Sangwan, R S ^b   Misra Bhattacharya, S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Chemotype; Infective larvae; Lymphatic filariasis; Th1 Th2 cytokine; Withaferin A; Withania somnifera

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; REACTIVE OXYGEN METABOLITE; WITHAFERIN A; WITHANIA SOMNIFERA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRUGIA MALAYI; BRUGIAN FILARIASIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FERTILITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LARVA; MALE; MASTOMYS; MASTOMYS COUCHA; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PLANT ROOT; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT DURATION; WITHANIA SOMNIFERA;

ANIMALS; BRUGIA MALAYI; CYTOKINES; ELEPHANTIASIS, FILARIAL; FEMALE; LARVA; MALE; MURINAE; PLANT EXTRACTS; PLANTS, MEDICINAL; RODENT DISEASES; TH1 CELLS; TH2 CELLS; TREATMENT OUTCOME; WITHANIA; WITHANOLIDES;

BRUGIA MALAYI; FILARIA; MASTOMYS COUCHA; WITHANIA SOMNIFERA;

EID: 84863251489     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2012.01352.x     Document Type: Article

References (42)

1. Singh PK, Ajay A, Kushwaha S, Tripathi RP & Bhattacharya SM. Towards novel antifilarial drugs: challenges and recent developments. Future Med Chem 2010; 2: 251-283.
2. Molyneux DH, Bradley M, Hoerauf A, Kyelem D & Taylor MJ. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol, 2003; 19: 516-522.
3. Anonymous. In The Wealth of India, (Raw Materials). New Delhi, India, CSIR, 1976; 10: 580-585.
4. Koduru S, Kumar R, Srinivasan S, Evers MB & Damodaran C. Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther 2010; 9: 202-210.
5. Sabina EP, Chandal S & Rasool MK. Inhibition of monosodium urate crystal-induced inflammation by Withaferin A. J Pharm Pharm Sci 2008; 11: 46-55.
6. Panjamurthy K, Manoharan S, Menon VP, Nirmal MR & Senthil N. Protective role of Withaferin-A on 7, 12-dimethylbenz (a) anthracene-induced genotoxicity in bone marrow of Syrian golden hamsters. J Biochem Mol Toxicol 2008; 22: 251-258.
7. Chandrashekar S, Solomon FE, Devi PU, Udupa N & Srinivasan KK. Antitumor and radio sensitizing effects of withaferin A on mouse ehrlich ascites carcinoma in vivo A. Acta Oncol 1996; 35: 95-100.
8. Bhattacharya SK, Satyan KS & Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 1997; 35: 236-239.
9. Kushwaha S, Roy S, Maity R, et al. Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice. Vaccine 2012; 30: 1083-1093.
10. Chaurasiya ND, Sangwan RS, Misra LN, Tuli R & Sangwan NS. Metabolic clustering of a core collection of Indian ginseng Withania somnifera Dunal through DNA, isoenzyme, polypeptide and withanolide profile diversity. Fitoterapia 2009; 80: 496-505.
11. Ash LR & Riley JM. Development of Brugia pahangi in the jird, Meriones unguiculatus, with notes on infections in other rodents. J Parasitol 1970; 56: 962-968.
12. Vedi S, Dangi A, Hajela K & Bhattacharya SM. Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models. Vaccine 2008; 26: 5997-6005.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
14. Speiser F & Weiss N. Comparative evaluation of 7 helminth antigens in the enzyme-linked immunosorbent assay (E.L.I.S.A.). Experientia 1979; 35: 1512-1514.
15. Singh M, Shakya S, Soni VK, Dangi A, Kumar N & Bhattacharya SM. The n-hexane and chloroform fractions of Piper betle L. trigger different arms of immune responses in BALB/c mice and exhibit antifilarial activity against human lymphatic filarid Brugia malayi. Int Immunopharmacol 2009; 9: 716-728.
16. O'Brien J, Wilson I, Orton T & Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2003; 267: 5421-5426.
17. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 2005; 5: 1749-1770.
18. Mittal A & Singh RP. Anticancer and immunomodulatory properties of Tinospora, Ranawat K.G. (ed.) herbal drugs: Ethnomedicine to modern medicine. DOI Berlin Heidelberg: Springer; 2009. 195-206.
19. Fulzele SV, Satturwar PM & Joshi SB. Study of Immunomodulatory activity of Haridradi Ghrita in rats. Indian J Pharmacol, 2003; 35: 51-54.
20. Satoskar RS, Bhandarkar SD & Rege NN. Pharmacology and Therapeutics, 15th edn. Mumbai, Popular prakashan, 1997: p1023.
21. Lai JH. Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases. Acta Pharmacol Sin 2002; 23: 1093-1101.
22. Samjon J, Sheeladevi R & Ravindran R. Oxidative stress in brain and antioxidant activity of Ocimum sanctum in noise exposure. Neurotoxicology 2007; 28: 679-685.
23. Brinker F. Herb Contraindications and Drug Interactions, 2nd ed. Sandy, Oregon, Eclectic Medical Publications, 1998: 36-92.
24. Bhatnagar M, Sisodia SS & Bhatnagar R. Antiulcer and antioxidant activity of Asparagus racemosus WIILD and Withania somnifera DUNN in rats. Ann N Y Acad Sci 2005; 1056: 261-278.
25. Singh DD, Dey CS & Bhutani KK. Downregulation of p34cdc2 expression with aqueous fraction from Withania somnifera for a possible molecular mechanism of anti-tumor and other pharmacological effects. Phytomedicine 2001; 8: 492-494.
26. Mishra LC, Singh BB & Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000; 5: 334-346.
27. Dhuley JN. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J Ethnopharmacol 2000; 70: 57-63.
28. Maizels R & Yazdanbakhsh M. T-cell regulation in helminth parasite infections: implications for inflammatory diseases. Chem Immunol Allergy 2008; 94: 112-123.
29. Spencer L, Shultz L & Rajan TV. T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4. Infect Immun 2003; 71: 3097-3106.
30. Harnett W & Harnett MM. What causes lymphocyte hyporesponsiveness during filarial nematode infections? Trends Parasitol 2006; 22: 105-110.
31. Gopinath R, Hanna LE, Swami VK, et al. Long-term persistence of cellular hyporesponsiveness to filarial antigens after clearance of microfilaremia. Am J Trop Med Hyg 1999; 60: 848-853.
32. Doetze A, Satoguina J, Burchard G, et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokine IL-10 and transforming growth factor-β but not by a Th1 to Th2 shift. Int Immunol 2000; 12: 623-630.
33. Taylor MD, Harris A, Nair MG, Maizels RM & allen JE. F4/80+ alternatively activated macrophages control CD4+ T cells hyporesponsiveness at sites peripheral to filarial infection. J Immunol 2006; 176: 6918-6927.
34. Soulsby EJ. The evasion of the immune response and immunological unresponsiveness: parasitic helminth infections. Immunol Lett 1987; 16: 315-320.
35. McSorley HJ, Harcus YM, Murray J, Taylor MD & Maizels RM. Expansion of Foxp3+ regulatory t cells in mice infected with the filarial parasite Brugia malayi. J Immunol 2008; 181: 6456-6466.
36. Sartono E, Kruize YCM, Partono F, Kurniawan A, Maizels RM & Yazdanbakhsh M. Specific T cell unresponsiveness in human filariasis: diversity in underlying mechanisms. Parasite Immunol 1995; 17: 587-594.
37. Babu S, Shultz LD, Klei TR & Rajan TV. Immunity in experimental murine filariasis: roles of T and B cells revisited. Infect Immun 1999; 67: 3166-3167.
38. Babu S, Blauvelt CP, Kumaraswami V & Nutman TB. Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence. J Immunol 2006; 176: 3248-3256.
39. Hoerauf A, Satoguina J, Saeftel M & Specht S. Immunomodulation by filarial nematodes. Parasite Immunol 2005; 27: 417-429.
40. Bowersock TL & Martin S. Vaccine delivery to animals. Adv Drug Deliv Rev 1999; 38: 167-194.
41. Gupta SS. Prospects and perspectives of natural plants products in medicine. Indian J Pharmacol 1994; 26: 1-12.
42. Berezin VE, Bogoyavlenskyi AP, Khudiakova SS, et al. Immunostimulatory complexes containing Eimeria tenella antigens and low toxicity plant saponins induce antibody response and provide protection from challenge in broiler chickens. Vet Parasitol 2010; 167: 28-35.